US4832956A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Disintegrating tablet and process for its preparation
Assignee: Individual
•
Filing: 1986-09-20
•
Granted: 1989-05-23
•
Expires: 2006-09-20
Abstract
Abstract A desintegration tablet contains the filler material in a form and/or size which when coming in contact with water at ambient temperature dissolves so slowly that the water absorption and the action of the desintegration agent are not affected. The grains are either coated with a layer of slowly dissolving substance, in particular a colloid or pseudo-colloid, or consist of a crushed melted substance having a grain size preferably of between 0.2 and 0.6 mm, e.g. mannitol, sorbital and/or xylitol.
Inventors
- 👤 Gerhard Gergely
- 👤 Thomas Gergely
- 👤 Irmgard Gergely
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 17:22
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2095; A61K9/0002; A61K9/0007
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
59 words
A tablet comprising at least one slowly or sparingly soluble pharmaceutically active compound, an effective amount of at least one disintegrating agent which disintegrates upon contact with water, and the balance comprising primarily at lest one soluble filler in a form which renders it more slowly soluble on contact with water than the disintegrating action of said disintegrating agent.
Claim 2
Dependent Claim
59 words
A tablet comprising at least one slowly or sparingly soluble pharmaceutically active compound, an effective amount of at least one disintegrating agent which disintegrates upon contact with water, and the balance comprising primarily at lest one soluble filler in a form which renders it more slowly soluble on contact with water than the disintegrating action of said disintegrating agent.
Claim 3
Dependent Claim
29 words
A tablet as claimed in claim 1, wherein the filler comprises a melt which has been comminuted into filler particles having a size of about 0.1 to 0.6 mm.
Claim 4
Dependent Claim
22 words
A tablet as claimed in claim 2, wherein the filler particles comprise at least one of the substances mannitol, orbitol and xylitol.
Claim 5
Dependent Claim
23 words
A tablet as claimed in claim 2, wherein the filler particles comprise at least one of the substances citric acid and adipic acid.
Claim 6
Dependent Claim
19 words
A tablet as claimed in claim 2, wherein the filler particles incorporate therein at least one pharmaceutically active compound.
Claim 7
Dependent Claim
17 words
A tablet as claimed in claim 2, the filler particles incorporate therein at least one disintegrating agent.
Claim 8
Dependent Claim
38 words
A tablet as claimed in claim 2, wherein the filler particles incorporate therein at least one material selected from the group consisting of another type of filler, a disintegrating agent, a pharmaceutically active compound and an auxiliary compound.
Claim 9
Dependent Claim
40 words
A tablet as claimed in claim 2, wherein, in addition to the active compound, the disintegrating agent and the filler, the tablet further comprises about 20% to about 331/3% by weight of readily soluble auxiliaries based on the total amount.
Claim 10
Dependent Claim
23 words
A multilayer tablet comprising at least one layer having a composition according to claim 2 wherein said tablet further comprises an effervescent layer.
Claim 11
Dependent Claim
13 words
A tablet as claimed in claim 2 wherein said filler comprises a carbohydrate.
Claim 12
Dependent Claim
23 words
A tablet as claimed in claim 2 wherein said disintegrating agent is selected from the group consisting of starch, silica, microcellulose, and polyvinylpyrrolidone.
Claim 13
Dependent Claim
13 words
A tablet as claimed in claim 1, wherein the filler comprises a melt.
Claim 14
Dependent Claim
18 words
The tablet of claim 2, wherein said melt has been comminuted into filler particles of a predetermined size.
Claim 15
Dependent Claim
20 words
A tablet as claimed in claim 3, wherein said filler particles have a size of about 0.1 to 0.6 nm.
Claim 16
Dependent Claim
21 words
A tablet as claimed in claim 1, wherein said soluble filler is coated with a layer of a slow dissolving material.
Claim 17
Dependent Claim
62 words
A tablet comprising a therapeutically effective amount o at least one slowly or sparingly soluble pharmaceutically active compound, an effective amount of at least one disintegrating agent, and the balance comprising primarily granules of a fused filler material, said filler material being selected from the group consisting of mannitol, sorbitol, xylitol, and combinations thereof, said disintegrating agent being dispersed within said granules.
Claim 18
Dependent Claim
62 words
A tablet comprising a therapeutically effective amount o at least one slowly or sparingly soluble pharmaceutically active compound, an effective amount of at least one disintegrating agent, and the balance comprising primarily granules of a fused filler material, said filler material being selected from the group consisting of mannitol, sorbitol, xylitol, and combinations thereof, said disintegrating agent being dispersed within said granules.
Claim 19
Dependent Claim
64 words
A process for the preparation of a tablet, comprising melting a filler material, dispersing an effective amount of at least one disintegrating agent in said melt, cooling said melt, comminuting said cooled melt into granules of a predetermined particle size, admixing a therapeutically effective amount of a slowly or sparingly soluble pharmaceutically active compound with said granules, and pressing said mixture into tablet form.
Claim 20
Dependent Claim
64 words
A process for the preparation of a tablet, comprising melting a filler material, dispersing an effective amount of at least one disintegrating agent in said melt, cooling said melt, comminuting said cooled melt into granules of a predetermined particle size, admixing a therapeutically effective amount of a slowly or sparingly soluble pharmaceutically active compound with said granules, and pressing said mixture into tablet form.
Claim 21
Dependent Claim
36 words
Process as claimed in claim 17, wherein at least one compound selected from the group consisting of another type of disintegrating agent, a pharmaceutically active compound and an auxiliary compound is also dispersed in the melt.
Claim 22
Dependent Claim
40 words
Process as claimed in claim 17, wherein at least one compound selected from the group consisting of a pharmaceutically active compound, an auxiliary compound and another type of disintegrating agent is admixed to said particles before pressing into a tablet.
References Cited (Backward Citations)
GB825892A
Cited
GB974917A
Cited
DE2416903A1
Cited
US4127645A
Cited
FR2383659A1
Cited
US4289751A
Cited
EP0052076A1
Cited
US4539198A
Cited
FR2552308A1
Cited
US4678661A
Cited
US4728513A
Cited
US4687662A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-05-22 | 1992-11-21 | 1993-05-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-05-22 | 1996-11-21 | 1997-05-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-05-22 | 2000-11-21 | 2001-05-23 | $7700.00 | Window Closed / Lapsed |